SEC Form 5 · accession 0001562180-19-000994
Sage Therapeutics, Inc. · SAGE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Albert Robichaud
Officer — Chief Scientific Officer
Period of report
Dec 31, 2018
Accepted (ET)
Feb 14, 2019 · 7:56 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001597553
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jun 29, 2018 | G | 875 | $0.00 | D | 94,962 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Reflects the amount of securities beneficially owned by the reporting person as of December 31, 2018, which reflects gifts of an aggregate of 875 shares by the reporting person on June 29, 2018, as well as 1,578 shares acquired by the reporting person pursuant to the issuer's employee stock purchase plan.